Aker Christopher Ray

Regulus Therapeutics Inc. · Sr. VP & General Counsel

Aker Christopher Ray is listed in public filings as officer: Sr. VP & General Counsel. This Aker Christopher Ray insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Regulus Therapeutics Inc. (RGLS). Investors use Aker Christopher Ray's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Regulus Therapeutics Inc.RGLS$6.4k5.1k sharesSellJan 14, 2025$1.26--